Key result
EU1794-4, a negative allosteric modulator, significantly reduced the fractional Ca2+ current of human NMDA receptors by 40% (from 9.4% to 5.7%) compared to control conditions.
Why the study?
Excessive Ca2+ influx through NMDAR causes excitotoxicity, but total receptor inhibition causes severe adverse effects, making selective reduction of Ca2+ entry while sparing Na+ current a potential neuroprotective strategy.
Does EU1794-4 reduce NMDA-mediated Ca2+ entry in human neurons derived from induced pluripotent stem cells?
Does EU1794-4 reduce NMDA-mediated Ca2+ entry in human neurons derived from induced pluripotent stem cells?
Effect estimate: 40% reduction
Absolute Event Rate: 5.7% vs 9.4%
p-value: p=0.025
EU1794-4 selectively reduces NMDA-mediated Ca2+ entry in human neurons, suggesting a potential neuroprotective strategy against excitotoxicity.
Should not yet change neuroprotection practice; leaves open whether new assay advances selective NMDAR Ca2+ targeting.
Excessive Ca 2+ influx through N-methyl-D-aspartate type glutamate receptors (NMDAR) is associated with excitotoxicity and neuronal death, but the inhibition of this receptor-channel causes severe adverse effects. Thus, a selective reduction of NMDA-mediated Ca 2+ entry, leaving unaltered the Na + current, could represent a valid neuroprotective strategy. We developed a new two-fluorophore approach to efficiently assess the Ca 2+ permeability of ligand-gated ion channels, including NMDARs, in different conditions. This technique was able to discriminate differential Ca 2+ /Na + permeation ratio through different receptor channels, and through the same channel in different conditions. With this method, we confirmed that EU1794-4, a negative allosteric modulator of NMDARs, decreased their Ca 2+ permeability. Furthermore, we measured for the first time the fractional Ca 2+ current (P f , i.e. the percentage of the total current carried by Ca 2+ ions) of human NMDARs in the presence of EU1794-4, exhibiting a 40% reduction in comparison to control conditions. EU1794-4 was also able to reduce NMDA-mediated Ca 2+ entry in human neurons derived from induced pluripotent stem cells. This last effect was stronger in the absence of extracellular Mg 2+ , but still significant in its presence, supporting the hypothesis to use NMDA-selective allosteric modulators to lower Ca 2+ influx in human neurons, to prevent Ca 2+ -dependent excitotoxicity and consequent neurodegeneration.
No takes yet. Share an insight, caveat, or question.
D’Andrea et al. (2024) studied Excitotoxicity and Neurodegeneration (in vitro model). EU1794-4 vs. Control conditions (untreated cells) was evaluated on Fractional Ca2+ current (Pf) of human NMDARs (40% reduction, p=0.025). EU1794-4, a negative allosteric modulator, significantly reduced the fractional Ca2+ current of human NMDA receptors by 40% (from 9.4% to 5.7%) compared to control conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: